Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
Open Access
- 27 June 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 911996
- https://doi.org/10.3389/fneur.2022.911996
Abstract
Objective: The main aim of this meta-analysis was to evaluate the predictors of the efficacy of continuous positive airway pressure (CPAP) in ameliorating excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA). Methods: Randomized controlled trials (RCTs) published between January 1994 and October 2021 were searched in the PubMed, EMBASE, and Cochrane Library databases. The weighted mean differences (WMDs) for the Epworth Sleepiness Scale (ESS) scores, the Multiple Sleep Latency Test (MSLT), and the Maintenance of Wakefulness Test (MWT) were pooled in STATA. Results: A total of 41 RCTs involving 7,332 patients were included. CPAP therapy was found to be significantly associated with changes in ESS (WMD = −2.14, P < 0.001), MSLT (WMD = 1.23, P < 0.001), and MWT (WMD = 1.6, P < 0.001). Meta-regression analysis and subgroup analysis indicated that in mild OSA, the efficacy of CPAP therapy for subjective EDS was limited to patients 2, baseline ESS score of ≥11, therapy adherence for ≥3 h/night, and treatment duration of ≥2 months. In moderate OSA, significant differences were observed in the changes in ESS among groups stratified by baseline ESS score (P = 0.005), adherence (P < 0.001), treatment duration (P = 0.009), and trial design type (P = 0.001). In severe OSA, this difference was observed among groups stratified by baseline BMI (P = 0.028), baseline ESS score (P = 0.001), and adherence (P = 0.047). Patients with moderate-severe OSA but not mild OSA showed significant improvements in MSLT. Patients with the age 2 had a more significant increase in MWT. Conclusion: Continuous positive airway pressure therapy improved subjective and objective sleepiness in patients with OSA. Age, baseline BMI, baseline ESS score, adherence, and duration of treatment may predict the effects of CPAP on EDS in patients with OSA. Notably, the baseline ESS scores and adherence were stable predictors regardless of OSA severity.This publication has 72 references indexed in Scilit:
- Effects of Continuous Positive Airway Pressure on Neurocognitive Function in Obstructive Sleep Apnea Patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES)Sleep, 2012
- Adherence to Continuous Positive Airway Pressure Therapy: The Challenge to Effective TreatmentProceedings of the American Thoracic Society, 2008
- Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetesThorax, 2007
- Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoeaThorax, 2007
- Cardiovascular and metabolic effects of CPAP in obese males with OSAEuropean Respiratory Journal, 2007
- Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepinessThorax, 2006
- Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysisThorax, 2006
- Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoeaThorax, 2005
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996